Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

hydrocortisone sodium succinate

The sodium salt of hydrocortisone succinate with glucocorticoid property. Hydrocortisone sodium succinate is chemically similar to the endogenous hormone that stimulates anti-inflammatory and immunosuppressive activities, in addition to exhibiting minor mineralocorticoid effects. This agent binds to intracellular glucocorticoid receptors and is translocated into the nucleus, where it initiates the transcription of glucocorticoid-responsive genes, such as various cytokines and lipocortins. Lipocortins inhibit phospholipase A2, thereby blocking the release of arachidonic acid from membrane phospholipids and preventing the synthesis of prostaglandins and leukotrienes, both potent mediators of inflammation.
Synonym:cortisol sodium succinate
Hycorace
Hydrocortisone 21-Sodium Succinate
Hydrocortisone Na succinate
Nordicort
Sodium hydrocortisone succinate
Solu-Cortef
Solu-Glyc
US brand name:A-Hydrocort
Emergent-EZ
Solu-Cortef
Foreign brand name:Buccalsone
Corlan
Cortop
Efcortelan
Flebocortid
Hidroc Clora
Hydro-Adreson
Hydrocort
Kinogen
Nordicort
Nositrol
Sinsurrene
Solu-Glyc
Abbreviation:HDC
Chemical structure:(11beta)-21-(3-carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, monosodium salt
Search NCI's Drug Dictionary